Vaccination in Special Populations Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Vaccination in Special Populations. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Vaccination in Special Populations Indian Medical PG Question 1: A girl child has had recurrent yeast and respiratory viral infections since she was 3 months old. Considering studies for her immune status, which of the following vaccines is contraindicated?
- A. Killed IPV (Inactivated Poliovirus Vaccine)
- B. DPT (Diphtheria, Pertussis, Tetanus)
- C. TT/Td (Tetanus toxoid)
- D. Measles/MMR (Correct Answer)
- E. Hepatitis B vaccine
Vaccination in Special Populations Explanation: ***Measles/MMR***
- This patient's history of **recurrent yeast and respiratory viral infections** suggests a potential **immunodeficiency**, which is a contraindication for **live attenuated vaccines** like MMR (Measles, Mumps, Rubella).
- Administering live attenuated vaccines to immunocompromised individuals can lead to **uncontrolled replication of the vaccine virus**, causing severe disease.
*Killed IPV (Inactivated Poliovirus Vaccine)*
- **Inactivated vaccines** do not contain live viruses and are generally safe for immunocompromised individuals.
- The patient's underlying immune status does not contraindicate killed vaccines, as there is **no risk of vaccine-induced infection**.
*DPT (Diphtheria, Pertussis, Tetanus)*
- DPT is a **non-live vaccine** (consisting of toxoids and inactivated bacterial components), making it safe for individuals with immunodeficiency.
- These vaccines do not pose a risk of causing the disease in immunocompromised patients, even if their **immune response is suboptimal**.
*TT/Td (Tetanus toxoid)*
- Tetanus toxoid vaccines are **inactivated vaccines** and are therefore safe for individuals with impaired immune function.
- The concern with immunodeficiency is the **ability to mount an effective immune response**, not the safety of the vaccine itself.
*Hepatitis B vaccine*
- Hepatitis B is a **recombinant inactivated vaccine** that is safe for immunocompromised patients.
- While the vaccine may have **reduced immunogenicity** in this population, it is not contraindicated and does not pose a risk of vaccine-induced disease.
Vaccination in Special Populations Indian Medical PG Question 2: In a 10-year-old school child under the school health program, which vaccine should be administered?
- A. DPT
- B. BCG
- C. Td (Correct Answer)
- D. MMR
Vaccination in Special Populations Explanation: ***Td (Tetanus-Diphtheria)***
- For a 10-year-old child under the school health program in India, the recommended vaccination is a booster dose of **Td (tetanus-diphtheria)**.
- This ensures continued **protection against tetanus and diphtheria**, as immunity from the primary series may wane over time.
- **Td is preferred over TT** (tetanus toxoid alone) as it provides protection against both tetanus and diphtheria.
- This is administered at **10 years and 16 years** as per the Indian Academy of Pediatrics immunization schedule.
*DPT*
- **DPT (diphtheria, pertussis, tetanus)** is administered in infancy and early childhood (at 6, 10, and 14 weeks, with boosters at 16-24 months and 4-6 years).
- The **pertussis component is not given** in later childhood or adolescence due to increased reactogenicity in older children.
*BCG*
- **BCG (Bacille Calmette-Guérin)** vaccine protects against tuberculosis and is given **at birth** in endemic areas like India.
- It is **not routinely administered** to a 10-year-old unless there are specific risk factors or documented non-vaccination status.
*MMR*
- **MMR (measles, mumps, rubella)** vaccine is given as **two doses**: first at 9-12 months and second at 16-24 months (or 4-6 years).
- A 10-year-old child would have **already completed** their MMR vaccination schedule.
Vaccination in Special Populations Indian Medical PG Question 3: Which vaccine is contraindicated in pregnancy?
- A. Influenza
- B. Rubella (Correct Answer)
- C. Tetanus toxoid
- D. Hepatitis B
Vaccination in Special Populations Explanation: ***Rubella***
- The **rubella vaccine** is a **live attenuated vaccine**, which carries a theoretical risk of fetal infection and congenital rubella syndrome if administered during pregnancy.
- For this reason, women are usually screened for immunity and vaccinated **pre-conception** or **postpartum**.
*Influenza*
- The **influenza vaccine** (inactivated form) is **recommended** during pregnancy to protect both the mother and newborn from severe influenza illness.
- It is **safe** and **effective** for pregnant women at any stage of gestation.
*Tetanus toxoid*
- The **tetanus toxoid vaccine** (Tdap or Td) is **recommended** during each pregnancy to provide passive immunity to the newborn against pertussis (whooping cough), as well as protecting the mother from tetanus and diphtheria.
- It is considered **safe** and ideally given between 27 and 36 weeks of gestation.
*Hepatitis B*
- The **hepatitis B vaccine** is **recommended** for pregnant women who are at high risk of hepatitis B infection, as a protective measure for both the mother and the fetus.
- It is an **inactivated vaccine** and has not been shown to cause adverse effects in pregnancy.
Vaccination in Special Populations Indian Medical PG Question 4: In which of the following disorders, vaccines are not contraindicated in the person suffering from that disease?
- A. Digeorge syndrome
- B. Wiskott Aldrich syndrome
- C. Ataxia telangiectasia
- D. Complement deficiency disorders (Correct Answer)
Vaccination in Special Populations Explanation: ***Complement deficiency disorders***
- While patients with **complement deficiencies** are susceptible to certain infections (especially by encapsulated bacteria), their adaptive immune system is generally intact.
- Therefore, most vaccines, including **live attenuated vaccines**, are not contraindicated; in fact, vaccination is crucial for preventing infections in these patients.
*Digeorge syndrome*
- This syndrome involves **thymic hypoplasia or aplasia**, leading to severe **T-cell immunodeficiency**.
- **Live attenuated vaccines** (e.g., MMR, varicella) are contraindicated due to the risk of uncontrolled replication of the vaccine strain in immunocompromised individuals.
*Wiskott Aldrich syndrome*
- This is an **X-linked immunodeficiency** characterized by immunodeficiency, eczema, and thrombocytopenia, involving defects in both T and B cell function, and **platelet dysfunction**.
- Due to profound immune defects, particularly in T-cell function, **live attenuated vaccines** are contraindicated.
*Ataxia telangiectasia*
- This is an autosomal recessive disorder causing **progressive cerebellar ataxia**, telangiectasias, and severe **combined immunodeficiency (SCID)-like features** affecting both T and B cells, as well as an increased risk of malignancy.
- Due to the severe immunodeficiency, **live attenuated vaccines** are contraindicated.
Vaccination in Special Populations Indian Medical PG Question 5: A child is a known case of HIV with a CD4 count of 50 . Which of the following vaccines should be avoided in this child?
- A. MMR
- B. TT
- C. BCG (Correct Answer)
- D. DPT
- E. OPV
Vaccination in Special Populations Explanation: ***BCG***
- **BCG vaccine** contains live attenuated bacteria and is **absolutely contraindicated** in severely immunocompromised individuals, such as an **HIV-positive child with a CD4 count of 50**, due to the risk of disseminated BCG infection.
- A **CD4 count of 50** indicates severe immunosuppression (AIDS stage), making live vaccines like BCG extremely unsafe.
- **This is the most strongly contraindicated vaccine** in this clinical scenario.
*MMR*
- **MMR (Measles, Mumps, Rubella) vaccine** is a live attenuated vaccine that is generally contraindicated in **severely immunocompromised HIV patients** with **CD4 count <200 cells/µL**.
- With a **CD4 count of 50**, this vaccine would typically be contraindicated due to severe immunosuppression.
- However, **BCG carries a higher risk** of disseminated infection and is more strongly contraindicated.
*OPV*
- **OPV (Oral Polio Vaccine)** is a live attenuated vaccine and is contraindicated in **immunocompromised individuals** including those with severe HIV infection.
- However, most vaccination programs now use **IPV (Inactivated Polio Vaccine)** which is safe for HIV-positive children.
- **BCG remains the most critical contraindication** in severe immunosuppression.
*TT*
- **TT (Tetanus Toxoid)** is an inactivated vaccine containing no live organisms and is **safe for immunocompromised individuals**, including those with HIV.
- Inactivated vaccines are generally recommended for HIV-positive individuals to provide protection against common infections.
*DPT*
- **DPT (Diphtheria, Pertussis, Tetanus)** is an inactivated vaccine and is **safe for immunocompromised children** with HIV.
- It does not pose a risk of infection from the vaccine itself and is crucial for protecting against these severe childhood diseases.
Vaccination in Special Populations Indian Medical PG Question 6: Who is known as the father of microbiology?
- A. Robert Brown
- B. J.C. Bose
- C. Louis Pasteur
- D. Antonie van Leeuwenhoek (Correct Answer)
Vaccination in Special Populations Explanation: ***Antonie van Leeuwenhoek***
- **Antonie van Leeuwenhoek** is widely recognized for his groundbreaking work in microscopy, which led to the discovery of microorganisms.
- He was the first to observe and accurately describe bacteria, protozoa, and other microscopic life forms, which he called "animalcules," using single-lens microscopes of his own design.
*Robert Brown*
- **Robert Brown** was a Scottish botanist known for his important contributions to botany, including the discovery of the cell nucleus and the description of Brownian motion.
- While significant in biology, his work primarily focused on plant structures and physics, not the direct study of microorganisms.
*J.C. Bose*
- **Jagadish Chandra Bose** was a polymath from British India, a physicist, biologist, botanist, and archaeologist.
- He made pioneering contributions to the investigation of radio and microwave optics, made significant contributions to plant science, and was an early writer of science fiction, but his work was not in microbiology.
*Louis Pasteur*
- **Louis Pasteur** is famous for his discoveries concerning the principles of vaccination, microbial fermentation, and pasteurization.
- While he is a pivotal figure in microbiology, often called the "father of modern microbiology" due to his foundational work on germ theory and disease, Van Leeuwenhoek predates him as the first to observe microorganisms.
Vaccination in Special Populations Indian Medical PG Question 7: All of the following regarding rotavirus vaccine are correct except?
- A. Oral vaccine
- B. Cannot be given after 6 months of age (Correct Answer)
- C. Available as monovalent and pentavalent
- D. Live vaccine
Vaccination in Special Populations Explanation: ***Cannot be given after 6 months of age***
- This statement is **INCORRECT**, making it the correct answer for this "EXCEPT" question.
- The rotavirus vaccine CAN be given after 6 months of age when completing the vaccination series.
- **Rotarix (RV1)**: First dose at 6-14 weeks, second dose by **8 months of age**
- **RotaTeq (RV5)**: First dose at 6-14 weeks, complete 3-dose series by **8 months of age**
- The key restriction is that the **first dose must be given between 6 to 14 weeks 6 days** (not after 15 weeks due to increased intussusception risk), but subsequent doses can be given after 6 months to complete the series.
*Oral vaccine*
- **CORRECT statement**: The rotavirus vaccine is an **oral vaccine**, administered as drops into the infant's mouth.
- This route avoids injections and improves compliance in pediatric immunization.
*Available as monovalent and pentavalent*
- **CORRECT statement**: Two types are available:
- **Rotarix (RV1)**: Monovalent vaccine targeting G1P[8] strain
- **RotaTeq (RV5)**: Pentavalent vaccine targeting G1, G2, G3, G4, and P[8] strains
- Both are highly effective in preventing severe rotavirus gastroenteritis.
*Live vaccine*
- **CORRECT statement**: Both rotavirus vaccines contain **live, attenuated viruses**.
- This stimulates robust mucosal and systemic immunity against rotavirus infection.
- Contraindicated in severe combined immunodeficiency (SCID) and after intussusception.
Vaccination in Special Populations Indian Medical PG Question 8: A young male came to the hospital with a clean-cut wound without any bleeding. The patient received a full course of tetanus vaccination 10 years ago. What is the best management for this patient?
- A. Single-dose tetanus toxoid (Correct Answer)
- B. Human tetanus immunoglobulin only
- C. Human tetanus immunoglobulin and a full course of vaccine
- D. No treatment required
Vaccination in Special Populations Explanation: ***Single-dose tetanus toxoid***
- For a **clean-cut wound** in a patient who completed a **primary tetanus vaccination series** and received their last dose more than 5 years ago but less than 10 years ago, a **single booster dose** of tetanus toxoid is recommended. [1]
- A booster ensures continued protection, as vaccine-induced immunity wanes over time, but the prior full course provides a robust anamnestic response with a single dose.
*Human tetanus immunoglobulin and a full course of vaccine*
- This regimen (tetanus immunoglobulin + vaccine) is typically reserved for patients with **unvaccinated status**, an **unknown vaccination history**, or a **severely contaminated wound** (e.g., rusty nail, soil contamination) who have not been fully vaccinated.
- The patient had a **clean-cut wound** and completed a full course of vaccination 10 years ago, making immunoglobulin unnecessary and a full course of vaccine excessive.
*Human tetanus immunoglobulin only*
- Administering **tetanus immunoglobulin alone** is appropriate for immediate, passive immunity in situations where a patient is unvaccinated or has an unknown vaccination status and has a significant risk of tetanus from a contaminated wound. [2]
- This patient has a clean wound and a history of full vaccination, so a booster is sufficient to stimulate active immunity.
*No treatment required*
- While the patient was fully vaccinated 10 years ago, the protection from tetanus vaccination can **wane over time**, especially after 5-10 years.
- A **booster dose** is crucial to maintain adequate protection against tetanus, even for a clean wound, given the 10-year interval since the last dose.
Vaccination in Special Populations Indian Medical PG Question 9: A person reports 4 hours after having a clean wound without laceration. He had taken TT 10 years before. The next step in management is:
- A. Single-dose TT (Correct Answer)
- B. No need for any vaccine
- C. Full course Tetanus vaccine to be given
- D. Full dose TT with TIG
Vaccination in Special Populations Explanation: ***Single-dose TT***
- For a **clean wound** when the last **tetanus toxoid (TT)** was given **10 years ago**, a **booster dose** is indicated as the protective immunity duration is **10 years**.
- **TT provides immunity for 10 years** for clean wounds; at the 10-year mark, the protective window has elapsed and requires a booster.
*No need for any vaccine*
- This would be correct only if the last TT dose was given **<10 years ago** (within the protective window).
- At exactly **10 years**, the immunity has waned and a **booster is required** for continued protection against tetanus.
*Full course Tetanus vaccine to be given*
- A **complete primary series (3 doses)** is only indicated for patients who are **unimmunized** or have **unknown vaccination history**.
- This patient has documented **prior TT immunization**, so only a **single booster dose** is needed, not a full course.
*Full dose TT with TIG*
- **Tetanus Immunoglobulin (TIG)** is reserved for **high-risk scenarios**: tetanus-prone wounds in patients with **inadequate immunization** (<3 doses) or **unknown vaccination status**.
- For a **clean wound** with documented prior immunization, **TIG is unnecessary** and represents over-treatment.
Vaccination in Special Populations Indian Medical PG Question 10: In a case of meningitis, Neisseria meningitides was grown in culture after 48 hours. Which measure is to be taken immediately ?
- A. Antibiotic treatment of contacts (Correct Answer)
- B. All of the options
- C. Isolation of contacts
- D. Vaccination of contacts
Vaccination in Special Populations Explanation: ***Correct: Antibiotic treatment of contacts***
- **Chemoprophylaxis is the immediate priority** for close contacts of confirmed *Neisseria meningitidis* cases
- Should be administered **within 24 hours** of case identification to prevent secondary cases
- **Recommended antibiotics**: Rifampicin (2 days), Ciprofloxacin (single dose), or Ceftriaxone (single dose)
- **Close contacts include**: household members, daycare contacts, anyone directly exposed to patient's oral secretions, healthcare workers exposed to respiratory secretions
- This is the **most effective immediate measure** to prevent transmission as meningococcal disease has a 2-10 day incubation period
*Incorrect: Isolation of contacts*
- **Contacts do NOT require isolation** according to WHO and CDC guidelines
- Only the **index patient** requires droplet precautions for 24 hours after starting appropriate antibiotics
- Contacts can continue normal activities while on chemoprophylaxis and should monitor for symptoms
- Isolating healthy contacts is not evidence-based and creates unnecessary social disruption
*Incorrect: Vaccination of contacts*
- Meningococcal vaccination is important for **long-term prevention** but not immediate post-exposure prophylaxis
- Vaccines take **7-14 days** to develop protective immunity, too slow for immediate protection
- Recommended in **outbreak settings** or for high-risk groups as an adjunct to chemoprophylaxis
- Does not replace the need for immediate antibiotic prophylaxis
*Incorrect: All of the options*
- **Only antibiotic chemoprophylaxis** is the immediate measure required
- Isolation of contacts is not standard practice for meningococcal disease
- Vaccination is a secondary/long-term measure, not immediate
- The question asks for the **immediate** measure, which is unequivocally chemoprophylaxis
More Vaccination in Special Populations Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
